Literature DB >> 15467573

The influence of obesity and diabetes on the prevalence of macrosomia.

Hugh M Ehrenberg1, Brian M Mercer, Patrick M Catalano.   

Abstract

OBJECTIVE: This study was undertaken to determine the relative contribution of abnormal pregravid maternal body habitus and diabetes on the prevalence of large-for-gestational-age infants. STUDY
DESIGN: Maternal and neonatal records for singleton term (> or =37 weeks' estimated gestational age) deliveries January 1997 through June 2001 were reviewed. Subjects were characterized by pregravid body mass index (BMI), divided into underweight (BMI <19.8 kg/m2), normal (BMI 19.8-25 kg/m2), overweight (BMI 25.1-30 kg/m2), and obese (BMI >30 kg/m2) subgroups. Diabetes was classified as gestational, treated with diet alone (A1GDM), or with insulin (A2GDM), and pregestaional diabetes (PDM). Newborn weight greater than the 90th percentile for gestational age, based on published local birth weight data, defined large for gestational age (LGA). The risk of LGA delivery for underweight, overweight, and obese women were compared with that of women with normal pregravid BMI. Multiple regression models, including parity, newborn sex, BMI, race, and diabetes, were constructed to examine the relative effect of abnormal BMI and diabetes on the risk of the delivery of an LGA infant.
RESULTS: Complete data for 12,950 deliveries were included (1,640 [13.0%] underweight, 2,991 [23.7%] overweight, and 2,928 [23.2%] obese). LGA delivery affected 11.8% of the study sample; 303 (2.3%) of subjects had A1GDM, whereas 94 (0.7%) had A2GDM, and 133 (1.6%) had PDM. Compared with normal BMI subjects, obese women were at elevated risk for LGA delivery (16.8% vs 10.5%; P < .0001) as were overweight women (12.3% vs 10.5%; P = .01). Diabetes was also a risk factor for LGA delivery (A1GDM: [29.4% vs 11.4%]; A2GDM: [29.8% vs 11.7%]; PDM: [38.3% vs 11.6%]; P < .0001 for each). Other risk factors for LGA delivery included parity (13.2% vs 9.5%; P < .0001), and male gender (14.3% vs 9.3%; P < .0001). Black race and low pregravid BMI were associated with a lower risk of LGA delivery (9.0% vs 13.7%; P < .0001) and (6.4% vs 10.5%; P = .006), respectively. Multiple regression revealed the independent influence of pregravid obesity and PDM, increasing the risk of LGA delivery (BMI >30kg/m 2 [Adjusted odds ratio (AOR) = 1.6]), and PDM (AOR = 4.4).
CONCLUSION: Obesity and pregestational diabetes are independently associated an increased risk of LGA delivery. The impact of abnormal body habitus on birth weight grows as BMI increases. Diabetes has the greatest affect on the normal and underweight population. With the increasing prevalence and relative frequency of overweight and obese women in pregnancy compared with diabetes (46.7% vs 4.1%), abnormal maternal body habitus exhibits the strongest influence on the prevalence of LGA delivery in our population.

Entities:  

Mesh:

Year:  2004        PMID: 15467573     DOI: 10.1016/j.ajog.2004.05.052

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  169 in total

1.  Are the neonatal outcomes similar in large-for-gestational age infants delivered by women with or without gestational diabetes mellitus?

Authors:  Esra E Onal; Ibrahim M Hirfanoglu; Serdar Beken; Nilgun Altuntas; Canan Turkyilmaz; Aysu Duyan Camurdan; Ozden Turan; Ebru Ergenekon; Esin Koc; Yildiz Atalay
Journal:  World J Pediatr       Date:  2011-06-01       Impact factor: 2.764

2.  Role of bone morphogenic protein-4 in gestational diabetes mellitus-related hypertension.

Authors:  Benshuo Cai; Juan Du
Journal:  Exp Ther Med       Date:  2021-05-13       Impact factor: 2.447

Review 3.  Management of diabetes in pregnancy.

Authors:  Jerasimos Ballas; Thomas R Moore; Gladys A Ramos
Journal:  Curr Diab Rep       Date:  2012-02       Impact factor: 4.810

4.  Obstetrical and neonatal outcomes of pregnancies following gastric bypass surgery: a retrospective cohort study in a French referral centre.

Authors:  Pietro Santulli; Laurent Mandelbrot; Enrico Facchiano; Chloé Dussaux; Pierre-François Ceccaldi; Séverine Ledoux; Simon Msika
Journal:  Obes Surg       Date:  2010-11       Impact factor: 4.129

5.  Activation of AMPK improves inflammation and insulin resistance in adipose tissue and skeletal muscle from pregnant women.

Authors:  Stella Liong; Martha Lappas
Journal:  J Physiol Biochem       Date:  2015-09-25       Impact factor: 4.158

6.  Chronic maternal infusion of full-length adiponectin in pregnant mice down-regulates placental amino acid transporter activity and expression and decreases fetal growth.

Authors:  Fredrick J Rosario; Michael A Schumacher; Jean Jiang; Yoshikatsu Kanai; Theresa L Powell; Thomas Jansson
Journal:  J Physiol       Date:  2012-01-30       Impact factor: 5.182

Review 7.  The Risks Associated With Obesity in Pregnancy.

Authors:  Johannes Stubert; Frank Reister; Steffi Hartmann; Wolfgang Janni
Journal:  Dtsch Arztebl Int       Date:  2018-04-20       Impact factor: 5.594

8.  The impact of maternal obesity on maternal and fetal health.

Authors:  Meaghan A Leddy; Michael L Power; Jay Schulkin
Journal:  Rev Obstet Gynecol       Date:  2008

9.  Association between Sonographic Estimated Fetal Weight and the Risk of Cesarean Delivery among Nulliparous Women with Diabetes in Pregnancy.

Authors:  Annie M Dude; William A Grobman; Lynn M Yee
Journal:  Am J Perinatol       Date:  2018-05-04       Impact factor: 1.862

10.  Nutrition and exercise prevent excess weight gain in overweight pregnant women.

Authors:  Michelle F Mottola; Isabelle Giroux; Robert Gratton; Jo-Anne Hammond; Anthony Hanley; Stewart Harris; Ruth McManus; Margie H Davenport; Maggie M Sopper
Journal:  Med Sci Sports Exerc       Date:  2010-02       Impact factor: 5.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.